HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,695,677 | +283.6% | 29,801 | +196.5% | 0.01% | +350.0% |
| Q2 2022 | $442,000 | -36.4% | 10,050 | -39.8% | 0.00% | 0.0% |
| Q1 2021 | $695,000 | -76.9% | 16,682 | -76.3% | 0.00% | -75.0% |
| Q4 2020 | $3,006,000 | +138.6% | 70,372 | +46.8% | 0.01% | +100.0% |
| Q3 2020 | $1,260,000 | -21.7% | 47,931 | -20.1% | 0.00% | -20.0% |
| Q2 2020 | $1,609,000 | -22.9% | 60,000 | -48.3% | 0.01% | 0.0% |
| Q1 2020 | $2,086,000 | +78.3% | 116,000 | +75.8% | 0.01% | +25.0% |
| Q4 2019 | $1,170,000 | +14.3% | 66,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,024,000 | -0.7% | 66,000 | +10.0% | 0.00% | 0.0% |
| Q2 2019 | $1,031,000 | -72.8% | 60,000 | -74.5% | 0.00% | -73.3% |
| Q1 2019 | $3,785,000 | +4.6% | 235,121 | -5.0% | 0.02% | -11.8% |
| Q4 2018 | $3,620,000 | -28.8% | 247,420 | -11.6% | 0.02% | -10.5% |
| Q3 2018 | $5,083,000 | -15.3% | 279,761 | -21.3% | 0.02% | -24.0% |
| Q2 2018 | $5,999,000 | -24.5% | 355,582 | -12.4% | 0.02% | -32.4% |
| Q1 2018 | $7,950,000 | -2.1% | 405,819 | +1.3% | 0.04% | 0.0% |
| Q4 2017 | $8,119,000 | +27.9% | 400,722 | +9.7% | 0.04% | +23.3% |
| Q3 2017 | $6,347,000 | +49.4% | 365,394 | +10.3% | 0.03% | +50.0% |
| Q2 2017 | $4,248,000 | -10.0% | 331,394 | -9.0% | 0.02% | -13.0% |
| Q1 2017 | $4,718,000 | +29.6% | 364,014 | -1.2% | 0.02% | +15.0% |
| Q4 2016 | $3,641,000 | -16.0% | 368,566 | +2.7% | 0.02% | -9.1% |
| Q3 2016 | $4,337,000 | +16.2% | 359,009 | -17.0% | 0.02% | +10.0% |
| Q2 2016 | $3,731,000 | -5.0% | 432,289 | +4.2% | 0.02% | 0.0% |
| Q1 2016 | $3,927,000 | -53.8% | 414,706 | -15.4% | 0.02% | -51.2% |
| Q4 2015 | $8,493,000 | +21.0% | 490,084 | -6.2% | 0.04% | +7.9% |
| Q3 2015 | $7,018,000 | +7.7% | 522,527 | +81.1% | 0.04% | +31.0% |
| Q2 2015 | $6,515,000 | – | 288,526 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |